Skip to main content

NanoVibronix, Inc.

For the period ended Nov 19, 2025. Filed Nov 19, 2025.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Nov 19, 2025 · Filed Nov 19, 2025

Use the contents to explore the available documents and sections.

FEED$1.03-69.3%Stored close · as of Sep 15, 2026
See the whole filing, with its images and exhibits

EX-99.1 · 2]https://sccm.org/communications/critical-care-statistics

2]https://sccm.org/communications/critical-care-statistics

●Vascular access - Leveraging the ENvue platform for Peripherally Inserted Central Catheter (PICC) lines and central-line placement expands its applicability beyond enteral feeding.
●Robotic tube placement - Automation of tube placement through robotic guidance can further improve accuracy, reduce procedural time and enhance patient safety.

Together, these opportunities demonstrate that ENvue is more than a single product. It is a broad navigation-technology platform with the potential to transform multiple critical-care procedures.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.